The Claim
Growth hormone infusion reduces FSP27 protein expression by approximately 60% in human subcutaneous adipose tissue within 270 minutes, and this reduction is associated with increased lipolysis and lipid droplet fragmentation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Growth hormone decreases FSP27 protein levels by about 60% in fat tissue under the skin within 4.5 hours, and this decrease occurs alongside increased fat breakdown and splitting of fat droplets.
See the scientific wording
Growth hormone reduces FSP27 protein expression by approximately 60% in human subcutaneous adipose tissue within 270 minutes of infusion, which is associated with increased lipolysis and lipid droplet fragmentation, suggesting a direct molecular mechanism linking growth hormone to fat breakdown in human adipocytes.
Growth hormone binds to fat cells and triggers a chain reaction that turns off a protein called FSP27, which normally holds fat inside droplets. When FSP27 is turned off, the fat droplets break apart and release fat into the bloodstream.
What the research says
1 studyStudy: Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes.
Growth hormone turns down a protein called FSP27 that normally stops fat cells from breaking down fat. When FSP27 is lowered, the fat cells release more fat — and this study shows exactly how growth hormone does that in human fat tissue.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.